Found 21 matching trials
RDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL. PHASE2 In this study, newly diagnosed non-elderly patients with Philadelphia chrom...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study N/A This is a prospective, multicenter, observational study aimed at exploring ...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of BiTE in Desensitization Therapy for Highly Sensitized Kidney Transplant Candidates With cPRA ≥ 90% PHASE4 This study is a prospective, open-label, two-arm exploratory clinical trial...
Show More Location
Multiple Locations
Learn More & Join Trial
Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD) PHASE1 This is a single-arm, open-label, multi-center phase I study using blinatum...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma PHASE2 A phase 2, multicenter, open-label, single arm clinical trial in adults wit...
Show More Learn More & Join Trial
Study Evaluating the Efficacy of 90Yttrium-epratuzumab in Adults With CD22+ Relapsed/Refractory B-ALL PHASE2 The investigators propose a randomized phase 2 study evaluating 90Y-epratuz...
Show More Location
CHU de Clermont-Ferrand
Learn More & Join Trial
A Phase 1b Open-Label Study Investigating the Safety and Pharmacokinetics of Administration of Subcutaneous Blinatumomab for the Treatment of Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma PHASE1 Primary Objective:
• To evaluate the safety and tolerability of subcutaneo...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia PHASE2 This is a prospective, open-label, single-arm, two-cohort Phase 2 clinical ...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia PHASE1 The main objective of this study is to evaluate the safety and efficacy of ...
Show More Status
Active Not Recruiting
Location
Lucile Packard Childrens Hospital Stanford
Learn More & Join Trial
Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL) PHASE2 This is a multicenter, non-randomized, open-label, phase II study evaluatin...
Show More Location
West Virginia University Cancer Institute
Learn More & Join Trial